These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11797064)

  • 1. Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.
    Mehta MA; Swainson R; Ogilvie AD; Sahakian J; Robbins TW
    Psychopharmacology (Berl); 2001 Dec; 159(1):10-20. PubMed ID: 11797064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory.
    Gibbs SE; D'Esposito M
    Psychopharmacology (Berl); 2005 Aug; 180(4):644-53. PubMed ID: 16001111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteers.
    Mehta MA; Hinton EC; Montgomery AJ; Bantick RA; Grasby PM
    J Psychopharmacol; 2005 Jan; 19(1):29-38. PubMed ID: 15671126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional magnetic resonance imaging study of the effects of pergolide, a dopamine receptor agonist, on component processes of working memory.
    Gibbs SE; D'Esposito M
    Neuroscience; 2006 Apr; 139(1):359-71. PubMed ID: 16458442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soya isoflavone supplementation enhances spatial working memory in men.
    Thorp AA; Sinn N; Buckley JD; Coates AM; Howe PR
    Br J Nutr; 2009 Nov; 102(9):1348-54. PubMed ID: 19480732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    J Psychopharmacol; 2006 Nov; 20(6):789-98. PubMed ID: 16478755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
    Fern-Pollak L; Whone AL; Brooks DJ; Mehta MA
    Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative neuropsychological test battery differentiates cognitive signatures of Fragile X and Down syndrome.
    Kogan CS; Boutet I; Cornish K; Graham GE; Berry-Kravis E; Drouin A; Milgram NW
    J Intellect Disabil Res; 2009 Feb; 53(2):125-42. PubMed ID: 19054268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine effects on episodic memory in young healthy volunteers.
    Montoya A; Lal S; Menear M; Duplessis E; Thavundayil J; Schmitz N; Lepage M
    Neuropsychologia; 2008 Jan; 46(1):292-300. PubMed ID: 17765272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents.
    Marighetto A; Valerio S; Philippin JN; Bertaina-Anglade V; Drieu la Rochelle C; Jaffard R; Morain P
    J Psychopharmacol; 2008 Jul; 22(5):511-21. PubMed ID: 18308794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive enhancing effects of modafinil in healthy volunteers.
    Turner DC; Robbins TW; Clark L; Aron AR; Dowson J; Sahakian BJ
    Psychopharmacology (Berl); 2003 Jan; 165(3):260-9. PubMed ID: 12417966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the dopamine dependency of human striatal signals during reward and punishment reversal learning.
    van der Schaaf ME; van Schouwenburg MR; Geurts DE; Schellekens AF; Buitelaar JK; Verkes RJ; Cools R
    Cereb Cortex; 2014 Mar; 24(3):633-42. PubMed ID: 23183711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.
    Coghill DR; Rhodes SM; Matthews K
    Biol Psychiatry; 2007 Nov; 62(9):954-62. PubMed ID: 17543895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modulatory effects of dopamine D1 and D2 receptor function on object working memory in humans.
    Bartholomeusz CF; Box G; Van Rooy C; Nathan PJ
    J Psychopharmacol; 2003 Mar; 17(1):9-15. PubMed ID: 12680735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study.
    Majer M; Welberg LA; Capuron L; Miller AH; Pagnoni G; Reeves WC
    Psychosom Med; 2008 Sep; 70(7):829-36. PubMed ID: 18606722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the marmoset monkey on computerized tasks of attention and working memory.
    Spinelli S; Pennanen L; Dettling AC; Feldon J; Higgins GA; Pryce CR
    Brain Res Cogn Brain Res; 2004 Apr; 19(2):123-37. PubMed ID: 15019709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive function deficits in children with fetal alcohol spectrum disorders (FASD) measured using the Cambridge Neuropsychological Tests Automated Battery (CANTAB).
    Green CR; Mihic AM; Nikkel SM; Stade BC; Rasmussen C; Munoz DP; Reynolds JN
    J Child Psychol Psychiatry; 2009 Jun; 50(6):688-97. PubMed ID: 19175817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
    Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
    Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies.
    Swerdlow NR; Eastvold A; Karban B; Ploum Y; Stephany N; Geyer MA; Cadenhead K; Auerbach PP
    Psychopharmacology (Berl); 2002 May; 161(2):189-201. PubMed ID: 11981599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease.
    Mehta MA; Sahakian BJ; McKenna PJ; Robbins TW
    Psychopharmacology (Berl); 1999 Sep; 146(2):162-74. PubMed ID: 10525751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.